CAPTRUST Financial Advisors’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CRMD
CAPTRUST Financial Advisors's CRMD Position: Q3 2026 in Review
CAPTRUST Financial Advisors increased its CorMedix (CRMD) stake by 2% in Q3 2026, buying an estimated $1.8K and bringing the position to 11,420 shares worth $87.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3166.
CAPTRUST Financial Advisors first reported a position in CRMD in Q1 2021 and has held it in 11 quarters since. The position peaked at $90K in Q4 2024. 187 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.
- CAPTRUST Financial Advisors held 11,420 shares of CorMedix worth $87.9K as of Q3 2026.
- CAPTRUST Financial Advisors bought 224 CorMedix shares in Q3 2026, an estimated $1.8K.
- CorMedix made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3166 holding.
- CAPTRUST Financial Advisors first reported a position in CorMedix in Q1 2021 and has held it in 11 quarters since.
- CAPTRUST Financial Advisors's CorMedix position peaked at $90K in Q4 2024.
- 187 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.